awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38239854-2B768D3B-A26E-4B50-82C1-766944897CF2
Q38239854-2B768D3B-A26E-4B50-82C1-766944897CF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38239854-2B768D3B-A26E-4B50-82C1-766944897CF2
Antibody-drug conjugates: an emerging modality for the treatment of cancer.
P2860
Q38239854-2B768D3B-A26E-4B50-82C1-766944897CF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38239854-2B768D3B-A26E-4B50-82C1-766944897CF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9f60b3b1f200253bc4a5f41bf15cfc6e9f5ff66c
P2860
Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer.